Streetbeat News

Revenues

F

Ford anticipates growth in global electric vehicle (EV) sales in 2024 and plans to create approximately 900 new jobs by adding a third crew at its Michigan Assembly Plant. This expansion is aimed at increasing production to meet the rising demand for EVs.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 12:44 pm

FPH

Shares of Five Point Holdings LLC (NYSE:FPH) surged after reporting strong Q4 FY23 results with revenues of $118.8 million, up from $17.0 million a year prior, primarily due to significant land sales. The company sold land for 583 homesites and closed two commercial land sales for a total of $276 million. Equity in earnings from unconsolidated entities was $24.0 million, and EPS increased to $0.39 from $0.15. The company has $353.8 million in cash and an additional $125.0 million in credit facility availability. CEO Dan Hedigan highlighted the team's focus on revenue generation and capital management despite economic challenges, and expressed optimism about the housing market due to supply shortages.

Portfolio Pulse from Lekha Gupta

January 19, 2024 | 12:39 pm

CMC

DBX

WBA

WSM

Insiders at Williams-Sonoma, Commercial Metals, Dropbox, and Walgreens Boots Alliance have recently sold shares of their companies. Williams-Sonoma CEO sold 20,000 shares after an analyst upgrade and price target increase. Commercial Metals' Executive Chairman sold 142,806 shares following an announcement of a share repurchase program increase. Dropbox's Chief Legal Officer and CFO sold shares as the company launched a new AI-powered search feature. Walgreens Boots Alliance's Director sold 15,209 shares after reporting a sales increase that beat consensus.

Portfolio Pulse from Avi Kapoor

January 19, 2024 | 12:28 pm

ALLY

Ally Financial (NYSE:ALLY) reported Q4 2023 earnings per share of $0.45, meeting analyst consensus estimates. Quarterly sales were $2.10 billion, surpassing the expected $2.00 billion by 5.22%, but representing a 2.91% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 12:26 pm

PRQR

ProQR Therapeutics presented new data on its Axiomer RNA editing technology, showing up to 70% editing of ACTB in the liver of non-human primates and mice. The platform's robust in vivo editing capabilities could have significant implications for the development of genetic treatments.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 12:12 pm

W

Wayfair anticipates delivering over $600M in Adjusted EBITDA for 2024, despite facing challenges in revenue growth due to persistent category weakness. The company will release full quarterly and annual results for the period ending December 31, 2023, during its February 2024 earnings call.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 12:10 pm

PEB

Pebblebrook Hotel Trust reported that their December operating results surpassed expectations, with a 7.1% year-over-year increase in same-property Hotel RevPAR and a 9.7% rise in non-room revenue.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 12:09 pm

PRQR

ProQR Therapeutics presented new data on its Axiomer RNA editing technology at Deaminet 2024, showing up to 70% editing efficiency in non-human primates and mice. The platform also demonstrated a functional effect in mice, with modulation of ANGPLT3 protein properties leading to an increase in LPL activity and a significant impact on biomarkers. Further data for pipeline programs AX-0810 and AX-1412 will be presented throughout 2024.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 12:06 pm

KIRK

Kirkland's reported a 3.1% increase in comparable sales for the first two months of fiscal Q4 ending December 30, 2023. This reflects a 1.5% rise in November and a 4.8% increase in December, year-over-year. The growth was attributed to robust in-store performance, with higher traffic and conversion rates.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 12:04 pm

ACCD

Accolade (NASDAQ:ACCD) has received mixed ratings from 7 analysts over the last quarter, with recent sentiment showing 1 bullish rating in the last 30 days compared to 2 bullish and 2 somewhat bullish ratings 1 month ago. The 12-month price target average has increased to $14.71, up 8.96% from the previous $13.50, with a high estimate of $17.00 and a low of $12.00. Analysts from firms including Needham, Truist Securities, Piper Sandler, Wells Fargo, Raymond James, and Stifel have updated their ratings and price targets, reflecting their views on Accolade's market performance and financials. Accolade's financial indicators show a positive revenue trend with a growth rate of 9.26% as of November 30, 2023, but it has a net margin of -21.2% and ROE of -4.83%, indicating potential profitability and efficiency challenges.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 12:01 pm